2023
The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy
Belzer A, Mortlock R, Pach J, Cohen J, Leventhal J. The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy. Journal Of The American Academy Of Dermatology 2023, 88: 1198-1200. PMID: 36634749, PMCID: PMC10121758, DOI: 10.1016/j.jaad.2023.01.002.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousEczemaHumansImmune Checkpoint InhibitorsNeoplasmsPsoriasisRetrospective StudiesSkin
2022
The spectrum of cutaneous immune-related adverse events in patients with skin of color
Belzer A, Mortlock R, Olamiju B, Olino K, Cohen J, Leventhal J. The spectrum of cutaneous immune-related adverse events in patients with skin of color. Journal Of The American Academy Of Dermatology 2022, 88: 1156-1158. PMID: 36470309, PMCID: PMC10838520, DOI: 10.1016/j.jaad.2022.11.051.Peer-Reviewed Original Research
2020
Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study.
Noorily AR, Criscito MC, Cohen JM, Brinster NK. Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study. American Journal Of Dermatopathology 2020, 43: 112-118. PMID: 32618707, DOI: 10.1097/dad.0000000000001711.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAdministration, OralAdultAgedAged, 80 and overBiological ProductsBiopsyDatabases, FactualDermatitis, Allergic ContactEczemaFemaleGlucocorticoidsHumansImmunosuppressive AgentsMaleMiddle AgedPredictive Value of TestsPsoriasisRemission InductionRetrospective StudiesSkinTreatment OutcomeYoung AdultConceptsAllergic contact dermatitisPsoriasis vulgarisClinical characteristicsHistopathological featuresEczematous changesDiagnostic workupSuccessful treatmentContact dermatitisOutcomes of patientsPercent of patientsHalf of patientsRetrospective chart reviewFeatures of psoriasisRetrospective clinicopathologic studyEczematous dermatosesEczematous featuresChart reviewClinicopathologic studyMost patientsSystemic therapyTopical glucocorticoidsHistopathologic featuresChallenging diagnosisClinicopathologic correlationTreatment modalities
2015
Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects
Xue Y, Cohen JM, Wright NA, Merola JF. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects. American Journal Of Clinical Dermatology 2015, 17: 147-162. PMID: 26649439, DOI: 10.1007/s40257-015-0167-z.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAntirheumatic AgentsArthritis, RheumatoidBiological TherapyDermatomyositisDrug EruptionsHumansLichenoid EruptionsLupus Erythematosus, CutaneousMelanomaPyoderma GangrenosumRheumatoid NoduleRheumatoid VasculitisSkin DiseasesSkin NeoplasmsSweet SyndromeTumor Necrosis Factor-alphaConceptsRheumatoid arthritisAdverse effectsBiologic disease-modifying agentsManagement of RAAnti-TNFα agentsRA disease activityCutaneous adverse effectsSystemic inflammatory disorderCutaneous side effectsDisease-modifying agentsGranulomatous skin disorderConnective tissue disordersNeutrophilic dermatosisRheumatoid vasculitisDisease activityAggressive treatmentRheumatoid nodulesCutaneous findingsClinical presentationTherapeutic challengeGranulomatous conditionsInflammatory disordersSkin signsCutaneous diseaseCutaneous effects